Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications
Autores de CIPF
Participantes ajenos a CIPF
- García-García R
- Mangas-Losada A
- Izquierdo-Altarejos P
Grupos de Investigación
Abstract
Several million patients with liver cirrhosis suffer minimal hepatic encephalopathy (MHE), with mild cognitive and coordination impairments that reduce their quality of life and life span. Hyperammonaemia and peripheral inflammation act synergistically to induce these neurological alterations. We propose that MHE appearance is because of the changes in peripheral immune system, which are transmitted to brain, leading to neuroinflammation that alters neurotransmission leading to cognitive and motor alterations. We summarize studies showing that MHE in cirrhotic patients is associated with alterations in the immune system and that patients died with HE show neuroinflammation in cerebellum, with microglial and astrocytic activation and Purkinje cell loss. We also summarize studies in animal models of MHE on the role of peripheral inflammation in neuroinflammation induction, how neuroinflammation alters neurotransmission and how this leads to cognitive and motor alterations. These studies identify therapeutic targets and treatments that improve cognitive and motor function. Rats with MHE show neuroinflammation in hippocampus and altered NMDA and AMPA receptor membrane expression, which impairs spatial learning and memory. Neuroinflammation in cerebellum is associated with altered GABA transporters and extracellular GABA, which impair motor coordination and learning in a Y maze. These alterations are reversed by treatments that reduce peripheral inflammation (anti-TNF, ibuprofen), neuroinflammation (sulphoraphane, p38 inhibitors), GABAergic tone (bicuculline, pregnenolone sulphate) or increase extracellular cGMP (sildenafil or cGMP). The mechanisms identified would also occur in other chronic diseases associated with inflammation, aging and some mental and neurodegenerative diseases. Treatments that improve MHE may also be beneficial to treat these pathologies.
Datos de la publicación
- ISSN/ISSNe:
- 1748-1708, 1748-1716
- Tipo:
- Review
- Páginas:
- -
- DOI:
- 10.1111/apha.13270
- PubMed:
- 30830722
Acta Physiologica WILEY
Citas Recibidas en Web of Science: 98
Documentos
- No hay documentos
Filiaciones
Keywords
- cognitive function; hepatic encephalopathy; hyperammonaemia; neuroinflammation; neurotransmission; peripheral inflammation
Proyectos asociados
Red de Transtornos Adictivos
Investigador Principal: CONSUELO GUERRI SIRERA
INSTITUTO DE SALUD CARLOS III . 2017
Bases moleculares de las alteraciones neurológicas (cognitivas y motoras) en hiperamonemia y encefalopatía hepática. Implicaciones terapéuticas
Investigador Principal: VICENTE FELIPO ORTS
MINISTERIO DE ECON. Y COMPET. . 2018
Mecanismos moleculares y cerebrales de las alteraciones cognitivas y motoras en hiperamonemia y encefalopatía hepática. Implicaciones terapeúticas y diagnósticas
Investigador Principal: VICENTE FELIPO ORTS
CONSELLERIA DE EDUCACION . 2018
Identification and modelling of molecular and cellular events of the inmune response associated to the appearence of minimal hepatic encephalopaty in cirrhotic patients
Investigador Principal: VICENTE FELIPO ORTS
FUNDACION RAMON ARECES . 2019